Philips broadens Inturis for Cardiology
Philips broadens Inturis for CardiologyEyeing the growing demand among smaller hospitals for scalable digital image management solutions, Philips Medical Systems North America has introduced two additions to its Inturis for Cardiology integrated
Philips broadens Inturis for Cardiology
Eyeing the growing demand among smaller hospitals for scalable digital image management solutions, Philips Medical Systems North America has introduced two additions to its Inturis for Cardiology integrated image and information system product line. Inturis NT is an entry-level solution for small to medium facilities with a single cath lab system that are seeking a cost-effective way to replace film with digital imaging and storage, according to the Shelton, CT-based firm. Inturis Lite is designed for departments with two to three labs and moderate imaging volume that want networking capabilities.
Philips has also released an advanced version of its original Inturis On-line system, Inturis On-line 2.2, for larger, high-volume departments with multiple labs from various manufacturers. All three products debuted at the TransCatheter Cardiovascular Therapeutics meeting in Washington, DC, last month.
- Search again
- Homepage
SNMMI: Can 18F-Fluciclovine PET/CT Bolster Detection of PCa Recurrence in the Prostate Bed?
June 24th 2025In an ongoing prospective study of patients with biochemical recurrence of PCa and an initial negative PSMA PET/CT, preliminary findings revealed positive 18F-fluciclovine PET/CT scans in over 54 percent of the cohort, according to a recent poster presentation at the SNMMI conference.
Could an Emerging PET Tracer be a Game Changer for Detecting Hepatocellular Carcinoma?
June 23rd 2025In addition to over 90 percent sensitivity in detecting hepatocellular carcinoma (HCC), the glypican-3 (GPC3) targeted PET tracer 68Ga-aGPC3-scFv appeared to be advantageous in identifying HCC tumors smaller than one centimeter, according to pilot study findings presented at the SNMMI conference.
SNMMI: What a New Meta-Analysis Reveals About Radiotracers for PET/CT Detection of PCa
June 22nd 2025While (68Ga)Ga-PSMA-11 offers a pooled sensitivity rate of 92 percent for prostate cancer, (18F)-based radiotracers may offer enhanced lesion detection as well as improved imaging flexibility, according to a meta-analysis presented at the Society for Nuclear Medicine and Molecular Imaging (SNMMI) conference.
